Navigation Links
Sanger Clinic Lends Its Name to New Heart Care Institute Serving NC and SC
Date:6/29/2009

CHARLOTTE, N.C., June 29 /PRNewswire/ -- Carolinas HealthCare System has organized a new business unit to guide the growth and development of cardiovascular services in North and South Carolina.

The newly formed Sanger Heart and Vascular Institute (SHVI) represents a combination of Sanger Clinic, Charlotte Cardiology Associates and Carolinas Heart and Vascular Institute. The Institute will continue serving as a regional referral center for highly specialized care.

Effective July 1, all three entities will begin the transition to Sanger nomenclature and previous names will be phased out.

More than 420 physicians and support staff will be affected by the new blending of cardiac services. These personnel currently work in more than 30 full-time and part-time medical offices spread across 16 counties in North and South Carolina. In addition, a large number of hospital-based personnel working in cardiac cath labs and operating rooms will come under the SHVI umbrella.

Joseph G. Piemont, President and Chief Operating Officer at Carolinas HealthCare, said the new structure "will create a seamless interaction between the care provided by Sanger and CCA staff in their medical offices and in the hospital settings in which they serve patients."

Dr. Paul Colavita, current president of Sanger Clinic and Carolinas Heart and Vascular Institute, will become President of SHVI, reporting to Paul Franz, Executive Vice President, Physician Services Group.

Colavita said SHVI patients will benefit from the Institute's ability to coordinate and integrate all aspects of patient care. "In addition," he said, "patients will profit from the expansion of highly specialized services into new locations and the sharing of best practices system-wide."


'/>"/>
SOURCE Carolinas HealthCare System
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Mayo Clinic Proceedings reviews deep brain stimulation to treat psychiatric diseases
2. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
3. OpusClinicalSuite(R) Achieves 08 CCHIT Certification as Inpatient EHR
4. Clinical Study Data Indicates that Celliant Reduces Pain
5. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
6. Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery
7. MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
8. Heritage Summit HealthCare Inc. Contracts with Mayo Clinic for Workers Compensation Care
9. MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans
10. Living Cell Technologies Diabetes Clinical Trial Authorized by New Zealand Government
11. Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over-the-Road Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4Welcome to the Biofuel Age of Flight 12593 1Welcome to the Biofuel Age of Flight 12593 2Welcome to the Biofuel Age of Flight 12593 3Students May Be Solution to Shortage of Medical Professionals 48719 1Students May Be Solution to Shortage of Medical Professionals 48719 2Students May Be Solution to Shortage of Medical Professionals 48719 3Students May Be Solution to Shortage of Medical Professionals 48719 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 1Hey Governator 21 Dont Terminate Senior Funding 21 48717 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 3Hey Governator 21 Dont Terminate Senior Funding 21 48717 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 5
Other Medicine Technology:Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 2Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 3Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 4Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 5Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 6Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 7Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 8BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 2BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 3BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 4BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 5BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 6BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 7